COMMUNIQUÉS West-GlobeNewswire

PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results
13/02/2025
MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024. Fourth quarter results Revenue of $39.2 million, a [...]
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/02/2025
BRISBANE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on February 8, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified [...]
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
13/02/2025
MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets [...]
Bio-Path Holdings Expands Global Patent Portfolio
13/02/2025
Builds on Global Intellectual Property Portfolio to Protect DNAbilize® Platform HOUSTON, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary [...]
InflaRx Announces Public Offering of Ordinary Shares and Pre-Funded Warrants
13/02/2025
JENA, Germany, Feb. 13, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that [...]
BridgeBio Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on February 20, 2025
13/02/2025
PALO ALTO, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that it [...]
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
13/02/2025
VALENCIA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for [...]
Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
13/02/2025
2024 Total Revenue of $560 million, exceeding guidance Crysvita® revenue of $410 million and Dojolvi® revenue of $88 million 2025 Financial Guidance: Total Revenue between $640 million to $670 million, Crysvita revenue [...]
Cytokinetics to Announce Fourth Quarter Results on February 27, 2025
13/02/2025
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter results on February 27, 2025 at 4:00 PM Eastern Time [...]
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
13/02/2025
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period and [...]
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
13/02/2025
Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 13, 2025 . Sanofi announces today the filing of its Form 20-F with the U.S. [...]
Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
13/02/2025
Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris, le 13 février 2025 . Sanofi annonce avoir déposé son Document d’Enregistrement Universel [...]
The Shift Towards Proactive Health: Biologic Pharmamedical Stands Firm Amidst Tariffs and Big Pharma Shakeup
13/02/2025
RICHMOND, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- As the healthcare and supplement industries experience seismic shifts—driven by new U.S. tariffs, growing scrutiny on Big Pharma, and rising pharmaceutical [...]
Over 120 Epilepsy Organizations Applaud the Introduction of the National Plan for Epilepsy Act in Congress
13/02/2025
The National Plan aims to support the 3.4 million people living with epilepsy in the United States through a unified approach, calling for bipartisan support. BOWIE, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Epilepsy [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025
13/02/2025
Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2025
13/02/2025
Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
Merus fera une présentation lors du Citi's 2025 Virtual Oncology Leadership Summit
13/02/2025
UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 13 févr. 2025 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq : MRUS), une société d’oncologie au stade clinique développant des anticorps de pleine longueur multispécifiques et [...]
Ultimovacs ASA: Cancellation of subsequent repair offering
13/02/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. [...]
Nutrify Today C-Suite Sumflex 2025 Shaping the Future of Nutraceuticals
13/02/2025
MUMBAI, India, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Nutrify Today will host C-Suite Sumflex 2025 on May 8-9, at the Trident and Oberoi Hotels in Mumbai, bringing together industry leaders, investors, and policymakers to [...]

Pages